Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05256641
Title Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

marginal zone B-cell lymphoma

lymphoplasmacytic lymphoma

follicular lymphoma

Waldenstroem's macroglobulinemia

B-cell lymphoma

Therapies

Acalabrutinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.